» Articles » PMID: 38409323

Identification of a Leucine-mediated Threshold Effect Governing Macrophage MTOR Signalling and Cardiovascular Risk

Abstract

High protein intake is common in western societies and is often promoted as part of a healthy lifestyle; however, amino-acid-mediated mammalian target of rapamycin (mTOR) signalling in macrophages has been implicated in the pathogenesis of ischaemic cardiovascular disease. In a series of clinical studies on male and female participants ( NCT03946774 and NCT03994367 ) that involved graded amounts of protein ingestion together with detailed plasma amino acid analysis and human monocyte/macrophage experiments, we identify leucine as the key activator of mTOR signalling in macrophages. We describe a threshold effect of high protein intake and circulating leucine on monocytes/macrophages wherein only protein in excess of ∼25 g per meal induces mTOR activation and functional effects. By designing specific diets modified in protein and leucine content representative of the intake in the general population, we confirm this threshold effect in mouse models and find ingestion of protein in excess of ∼22% of dietary energy requirements drives atherosclerosis in male mice. These data demonstrate a mechanistic basis for the adverse impact of excessive dietary protein on cardiovascular risk.

Citing Articles

The Protein Link: Leveraging Precision Nutrition to Shape Cardiovascular Wellness.

Ajam A, Cosme Jr C, Yeh Y, Zhang X, Razani B Precis Nutr. 2025; 3(4).

PMID: 39867457 PMC: 11759316.


Unraveling the transcriptomic effects of leucine supplementation on muscle growth and performance in basketball athletes.

Wang S, Guo W, Dong R PLoS One. 2025; 20(1):e0316603.

PMID: 39854288 PMC: 11761164. DOI: 10.1371/journal.pone.0316603.


Amino Acid Metabolism and Autophagy in Atherosclerotic Cardiovascular Disease.

Wu Y, Avcilar-Kucukgoze I, Santovito D, Atzler D Biomolecules. 2025; 14(12.

PMID: 39766264 PMC: 11673637. DOI: 10.3390/biom14121557.


Dietary Factors and Cardiovascular Diseases: Comprehensive Insights from the National Health and Nutrition Examination Survey 2017-2020 and Mendelian Randomization Analysis.

Wang C, Gao Y, Smerin D, Amin M, Chen Z, Jian Z Nutrients. 2024; 16(22).

PMID: 39599614 PMC: 11597483. DOI: 10.3390/nu16223829.


Glutamine-glutamate imbalance in the pathogenesis of cardiovascular disease.

Liu Z, Ajam A, Huang J, Yeh Y, Razani B Nat Cardiovasc Res. 2024; 3(12):1377-1379.

PMID: 39562783 DOI: 10.1038/s44161-024-00575-0.


References
1.
Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E . Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther. 2014; 146:104-19. PMC: 4304984. DOI: 10.1016/j.pharmthera.2014.09.009. View

2.
Zhang X, Sergin I, Evans T, Jeong S, Rodriguez-Velez A, Kapoor D . High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. Nat Metab. 2020; 2(1):110-125. PMC: 7053091. DOI: 10.1038/s42255-019-0162-4. View

3.
Wolfson R, Chantranupong L, Saxton R, Shen K, Scaria S, Cantor J . Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. 2015; 351(6268):43-8. PMC: 4698017. DOI: 10.1126/science.aab2674. View

4.
Saxton R, Chantranupong L, Knockenhauer K, Schwartz T, Sabatini D . Mechanism of arginine sensing by CASTOR1 upstream of mTORC1. Nature. 2016; 536(7615):229-33. PMC: 4988899. DOI: 10.1038/nature19079. View

5.
Goberdhan D, Wilson C, Harris A . Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot. Cell Metab. 2016; 23(4):580-9. PMC: 5067300. DOI: 10.1016/j.cmet.2016.03.013. View